Nanfang Hospital, Southern Medical University

This study tests whether a 48-week course of pegylated interferon alfa-2b can help children and teens (ages 3 to 17) with chronic hepatitis B achieve a functional cure, meaning the virus is no longer active. 113 participants will either receive the drug or be observed on standard…

This study tests whether adding Babao Dan Capsule (a traditional Chinese medicine) to standard antiviral treatment can lower the chance of developing liver cancer in people with hepatitis B-related cirrhosis who are at high risk. About 1,034 adults aged 18-65 with a specific trad…

This study tests whether butylphthalide can reduce brain swelling and improve recovery in 100 adults who had a major stroke and received a procedure to reopen a blocked artery. Participants must be treated within 24 hours of stroke onset. The goal is to see if the drug helps cont…

This study tests whether a drug called edaravone dexborneol can help people who have both a stroke and active cancer recover better. About 144 adults aged 18-80 will receive either the drug or standard care. The goal is to see if the drug improves brain function and is safe for t…

This study tests whether adding a PCSK9 inhibitor (a cholesterol-lowering drug) to standard care helps people recover better after a stroke caused by a blocked artery. About 478 adults with acute ischemic stroke who undergo endovascular therapy (a procedure to reopen the artery) …

This study tests whether adding a targeted drug (dalpiciclib) and hormone therapy to brain radiation can help control breast cancer that has spread to the brain. About 46 women with HR-positive, HER2-negative advanced breast cancer will receive the combination treatment. The goal…

This study tests a drug called nanocrystalline megestrol acetate to see if it can help prevent weight loss and improve appetite in people with advanced liver cancer who are already receiving standard treatments. About 88 participants will be randomly assigned to receive either th…

This study will see if using artificial intelligence (AI) helps pathologists (doctors who study tissue samples) diagnose diseases more accurately and quickly. About 2060 patients and many pathologists will take part. Doctors will either use an AI tool or read slides the usual way…